Production resumes at Evonik methionine manufacturing plants in Antwerp, Belgium

Evonik has stated that the force majeure announced on Tuesday 12 November has now ended.

An issue with the hydrocyanic acid (HCN) supply caused a temporary shutdown of its methionine manufacturing facilities in Antwerp.

Dr. Emmanuel Auer, Head of Animal Nutrition Business Line at Evonik said: “We are pleased that we could solve the issue and resume MetAMINO^® production.

“We would like to thank our customers for the patience and support shown whilst we resolved the situation.”